Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Micro<scp>RNA</scp> signatures and treatment response in patients with advanced classical Hodgkin lymphoma

1 Jun 2013

Abstract excerpt

Although specific microRNA (miRNA) signatures in classical Hodgkin lymphoma (cHL) have been proposed, their relationship with clinical outcome remains unclear. Despite treatment advances, a substantial subset of patients with advanced cHL are refractory to standard therapies based on adriamycin and its variants. Global miRNA expression data of 29 advanced cHL patients and five cHL-derived cell lines were used to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Circular RNAs in diseases
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23725219
DOI: 10.1111/bjh.12390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Micro<scp>RNA</scp> signatures and treatment response in patients with advanced classical Hodgkin lymphomaPMID 23725219Read ↗

Whole-genome Sequencing of Reed-sternberg Cells Identifies Outcome Determinants in Hodgkin LymphomaSemantic proximity Read ↗

Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphomaSemantic proximity Read ↗

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict OutcomeSemantic proximity Read ↗

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcomeSemantic proximity Read ↗

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein responseSemantic proximity Read ↗

Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin LymphomaSemantic proximity Read ↗

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein responseSemantic proximity Read ↗

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasionSemantic proximity Read ↗

Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaSemantic proximity Read ↗

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcomeSemantic proximity Read ↗

9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.Semantic proximity Read ↗

Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.